Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · IEX Real-Time Price · USD
1.040
-0.050 (-4.59%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $4.40 million as of July 2, 2024. Its market cap has decreased by -32.27% in one year.
Market Cap
4.40M
Enterprise Value
-622.47K
1-Year Change
-32.27%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $4.40M, a decrease of -83.26%. That is a compound annual growth rate of -26.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 4.40M | 91.30% |
| Dec 29, 2023 | 2.30M | -60.34% |
| Dec 30, 2022 | 5.80M | -89.66% |
| Dec 31, 2021 | 56.10M | 131.82% |
| Dec 31, 2020 | 24.20M | -2.81% |
| Dec 31, 2019 | 24.90M | -25.89% |
| Dec 31, 2018 | 33.60M | 27.76% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Titan Pharmaceuticals | 5.09M |
| Synaptogenix | 5.06M |
| Venus Concept | 4.97M |
| Leafly Holdings | 4.95M |
| Hoth Therapeutics | 4.87M |
| Enveric Biosciences | 4.85M |
| Bright Minds Biosciences | 4.84M |
| Aethlon Medical | 4.60M |